• Roche received CE marking for its cobas smart e immunoanalyzer, expanding its diagnostic testing portfolio for smaller laboratories.
• The compact platform has a planned menu of over 100 assays, enabling smaller facilities to bring testing in-house.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270200OMX_____CNEWS_EN_GNW1001279954_en) on October 27, 2026, and is solely responsible for the information contained therein.